Gesval
Overview
Gesval is the technology transfer and investment firm of the University of Liège and the CHU de Liège, focused on commercializing university research by managing intellectual property and investing in spin-off companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Trasis SA | Jun 2004 | Seed | Lead |
| Ampacimon | Oct 2023 | Series C | Co-investor |
| THERAtRAME | Sep 2022 | Seed | Co-investor |
| Catalya | Jun 2026 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Gesval based?
Gesval is headquartered in Liège, Belgium.
When was Gesval founded?
Gesval was founded in 1991.
How many portfolio companies does Gesval have?
Gesval has 4 portfolio companies in Caplight's dataset.
What are some companies in Gesval's portfolio?
Portfolio companies visible on Caplight include Trasis SA, Ampacimon, THERAtRAME, Catalya.
What was Gesval's most recent investment shown here?
Gesval's most recent investment in this portfolio sample was in Catalya in 2026.
What sectors does Gesval focus on?
Gesval focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Gesval focus on?
Gesval typically invests at the Early stage.